You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 24, 2024

Claims for Patent: 9,526,707

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 9,526,707

Title:	Methods for treating or preventing neuroinflammation or autoimmune diseases
Abstract:	Disclosed herein are ribonucleotide reductase inhibitors, compositions comprising ribonucleotide reductase inhibitors, and methods for treating and/or preventing autoimmune diseases and neuroinflammatory diseases with the ribonucleotide reductase inhibitors.
Inventor(s):	Elford; Howard L. (Richmond, VA)
Assignee:
Application Number:	12/228,440
Patent Claims:	1. A method of treating multiple sclerosis comprising administering a compound selected from the group consisting of: ##STR00024## 2. The method of claim 1, wherein the compound is ##STR00025## 3. The method of claim 1, wherein the compound is ##STR00026## 4. The method of claim 1, wherein the compound is ##STR00027## 5. The method of claim 1, wherein the compound is ##STR00028## 6. The method according to claim 1, further comprising administering one or more compounds selected from the group consisting of glatiramer acetate, mitoxantrone, tysabri, interferon .beta.1-a, interferon .beta.1-b, interferon .alpha., methylprednisolone, prednisone, cyclophosphamide, methotrexate, azathioprine, cladribine, cyclosporine, FTY-720 (fingolimod), MBP8298 (dirucotide), liquinimod, 4-aminopyridine (4AP), lovastatin, and pravastatin.

Details for Patent 9,526,707

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Biogen Inc.	TYSABRI	natalizumab	Injection	125104	11/23/2004	⤷ Try a Trial	2027-08-13
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.